York Capital Management Global Advisors, LLC Biomarin Pharmaceutical Inc Transaction History

York Capital Management Global Advisors, LLC

$455 Million
Q2 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 18, 2020	SELL	$64.27 - $86.37 $48.1 Million - $64.6 Million	-748,371 Closed	0 $0
Q3 2019 Nov 15, 2019	SELL	$67.4 - $85.11 $24.8 Million - $31.4 Million	-368,356 Reduced 32.99%	748,371 $50.4 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $89.7 Million - $105 Million	1,116,727 New	1,116,727 $95.6 Million

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

Black Rock Inc. New York, NY

22.7M
Shares

$1.6 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$1.34 Billion
0.03% of portfolio
Primecap Management CO Pasadena, CA

18.8M
Shares

$1.33 Billion
1.14% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$983 Million
0.72% of portfolio
Capital Research Global Investors Los Angeles, CA

9.69M
Shares

$684 Million
0.18% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of York Capital Management Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on York Capital Management Global Advisors, LLC with notifications on news.

Account